{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:37:59Z","timestamp":1789022279414,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12875-018-0744-3","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T03:54:49Z","timestamp":1525838089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study"],"prefix":"10.1186","volume":"19","author":[{"given":"Allyce B.","family":"Counsell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-564X","authenticated-orcid":false,"given":"Amy D.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa T.","family":"Baysari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diluk R. W.","family":"Kannangara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard O.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"744_CR1","doi-asserted-by":"publisher","first-page":"f5648","DOI":"10.1136\/bmj.f5648","volume":"347","author":"E Roddy","year":"2013","unstructured":"Roddy E, Mallen CD, Doherty M. Gout. BMJ. 2013;347:f5648.","journal-title":"BMJ"},{"issue":"11","key":"744_CR2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jpain.2011.06.009","volume":"12","author":"HS Smith","year":"2011","unstructured":"Smith HS, Bracken D, Smith JM. Gout: current insights and future perspectives. J Pain. 2011;12(11):1113\u201329.","journal-title":"J Pain"},{"issue":"10","key":"744_CR3","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and nutrition examination survey 2007\u20132008. Arthritis Rheum. 2011;63(10):3136\u201341.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"744_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"C-F Kuo","year":"2015","unstructured":"Kuo C-F, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649\u201362.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"744_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","volume":"74","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74(4):661\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"744_CR6","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1445-5994.2012.02794.x","volume":"42","author":"P Robinson","year":"2012","unstructured":"Robinson P, Taylor W, Merriman T. Systematic review of the prevalence of gout and hyperuricaemia in Australia. Intern Med J. 2012;42(9):997\u20131007.","journal-title":"Intern Med J"},{"issue":"9","key":"744_CR7","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3899\/jrheum.150310","volume":"42","author":"PC Robinson","year":"2015","unstructured":"Robinson PC, Taylor WJ, Dalbeth N. An observational study of gout prevalence and quality of care in a national Australian general practice population. J Rheumatol. 2015;42(9):1702\u20137.","journal-title":"J Rheumatol"},{"issue":"8","key":"744_CR8","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","volume":"46","author":"KM Jordan","year":"2007","unstructured":"Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, et al. British Society for Rheumatology and British health professionals in rheumatology guideline for the management of gout. Rheumatology (Oxford). 2007;46(8):1372\u20134.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"744_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 2012;64(10):1431\u201346.","journal-title":"Arthritis Care Res"},{"issue":"10","key":"744_CR10","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/acr.21773","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. 2012;64(10):1447\u201361.","journal-title":"Arthritis Care Res"},{"issue":"3","key":"744_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/1756-185X.12557","volume":"18","author":"SW Graf","year":"2015","unstructured":"Graf SW, Whittle SL, Wechalekar MD, Moi JH, Barrett C, Hill CL, et al. Australian and New Zealand recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion in the 3e initiative. Int J Rheum Dis. 2015;18(3):341\u201351.","journal-title":"Int J Rheum Dis"},{"key":"744_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76:29\u201342.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"744_CR13","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/rheumatology\/ket158","volume":"52","author":"LR Harrold","year":"2013","unstructured":"Harrold LR, Mazor KM, Negron A, Ogarek J, Firneno C, Yood RA. Primary care providers\u2019 knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. Rheumatology (Oxford). 2013;52(9):1623\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"744_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3899\/jrheum.150607","volume":"43","author":"S Vaccher","year":"2016","unstructured":"Vaccher S, Kannangara DRW, Baysari MT, Reath J, Zwar N, Williams KM, et al. Barriers to care in gout: from prescriber to patient. J Rheumatol. 2016;43(1):144\u20139.","journal-title":"J Rheumatol"},{"issue":"1","key":"744_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1471-2296-14-170","volume":"14","author":"E Cottrell","year":"2013","unstructured":"Cottrell E, Crabtree V, Edwards JJ, Roddy E. Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice. BMC Fam Pract. 2013;14(1):170.","journal-title":"BMC Fam Pract"},{"issue":"2","key":"744_CR16","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/ar2659","volume":"11","author":"LR Harrold","year":"2009","unstructured":"Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA, et al. Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther. 2009;11(2):R46.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"744_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1592\/phco.28.4.437","volume":"28","author":"BA Briesacher","year":"2008","unstructured":"Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437\u201343.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"744_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10067-014-2823-8","volume":"35","author":"B McGowan","year":"2016","unstructured":"McGowan B, Bennett K, Silke C, Whelan B. Adherence and persistence to urate-lowering therapies in the Irish setting. Clin Rheumatol. 2016;35(3):715\u201321.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"744_CR19","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","volume":"71","author":"K Spencer","year":"2012","unstructured":"Spencer K, Carr A, Doherty M. Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis. 2012;71(9):1490\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"744_CR20","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","volume":"72","author":"F Rees","year":"2013","unstructured":"Rees F, Jenkins W, Doherty M. Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann Rheum Dis. 2013;72(6):826\u201330.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"744_CR21","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1345\/aph.1G165","volume":"39","author":"SI Benrimoj","year":"2005","unstructured":"Benrimoj SI, Roberts AS. Providing patient care in community pharmacies in Australia. Ann Pharmacother. 2005;39(11):1911\u20137.","journal-title":"Ann Pharmacother"},{"key":"744_CR22","unstructured":"The Pharmacy Guild of Australia. Community pharmacy. 2014. https:\/\/www.guild.org.au\/__data\/assets\/pdf_file\/0010\/6121\/pgoa-submission-to-the-competition-policy-review-june-2014_573492_3.pdf . Accessed 1 Oct 2017."},{"issue":"5","key":"744_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3109\/13561820.2011.585725","volume":"25","author":"C Van","year":"2011","unstructured":"Van C, Mitchell B, Krass I. General practitioner\u2013pharmacist interactions in professional pharmacy services. J Interprof Care. 2011;25(5):366\u201372.","journal-title":"J Interprof Care"},{"key":"744_CR24","doi-asserted-by":"publisher","unstructured":"Elliott RA, Boyd MJ, Salema N-E, Davies J, Barber N, Mehta RL, et al. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the new medicine service. BMJ Qual Saf. 2015; https:\/\/doi.org\/10.1136\/bmjqs-2015-004400 .","DOI":"10.1136\/bmjqs-2015-004400"},{"issue":"5","key":"744_CR25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1365-2710.2010.01218.x","volume":"36","author":"E Mehuys","year":"2011","unstructured":"Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, et al. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. J Clin Pharm Ther. 2011;36(5):602\u201313.","journal-title":"J Clin Pharm Ther"},{"issue":"10","key":"744_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/bmjqs-2015-004670","volume":"25","author":"I Lyons","year":"2016","unstructured":"Lyons I, Barber N, Raynor DK, Wei L. The medicines advice service evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence. BMJ Qual Saf. 2016;25(10):759\u201369.","journal-title":"BMJ Qual Saf"},{"issue":"3","key":"744_CR27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/15-234","volume":"20","author":"R Goldfien","year":"2016","unstructured":"Goldfien R, Pressman A, Jacobson A, Ng M, Avins A. A pharmacist-staffed, virtual gout management clinic for achieving target serum uric acid levels: a randomized clinical trial. Perm J. 2016;20(3):18\u201323.","journal-title":"Perm J"},{"issue":"4","key":"744_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/13645570701401305","volume":"11","author":"C Noy","year":"2008","unstructured":"Noy C. Sampling knowledge: the hermeneutics of snowball sampling in qualitative research. Int J Soc Res Methodol. 2008;11(4):327\u201344.","journal-title":"Int J Soc Res Methodol"},{"issue":"6","key":"744_CR29","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/fampra\/13.6.522","volume":"13","author":"MN Marshall","year":"1996","unstructured":"Marshall MN. Sampling for qualitative research. Fam Pract. 1996;13(6):522\u20136.","journal-title":"Fam Pract"},{"issue":"6","key":"744_CR30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.sapharm.2012.11.003","volume":"9","author":"SS McMillan","year":"2013","unstructured":"McMillan SS, Wheeler AJ, Sav A, King MA, Whitty JA, Kendall E, et al. Community pharmacy in Australia: a health hub destination of the future. Res Social Adm Pharm. 2013;9(6):863\u201375.","journal-title":"Res Social Adm Pharm"},{"issue":"7","key":"744_CR31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008. Am J Med. 2012;125(7):679\u201387. e1","journal-title":"Am J Med"},{"issue":"5","key":"744_CR32","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10067-015-3039-2","volume":"35","author":"P Chandratre","year":"2016","unstructured":"Chandratre P, Mallen CD, Roddy E, Liddle J, Richardson J. \u201cYou want to get on with the rest of your life\u201d: a qualitative study of health-related quality of life in gout. Clin Rheumatol. 2016;35(5):1197\u2013205.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"744_CR33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4212\/cjhp.v68i5.1492","volume":"68","author":"RJ Moles","year":"2015","unstructured":"Moles RJ, Stehlik P. Pharmacy practice in Australia. Can J Hosp Pharm. 2015;68(5):418\u201326.","journal-title":"Can J Hosp Pharm"},{"issue":"12","key":"744_CR34","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1345\/aph.1P281","volume":"44","author":"SR Eussen","year":"2010","unstructured":"Eussen SR, MEvd E, Klungel OH, Rompelberg CJ, Garssen J, Oosterveld MH, et al. A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial. Ann Pharmacother. 2010;44(12):1905\u201313.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"744_CR35","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3899\/jrheum.141442","volume":"42","author":"ME Johnston","year":"2015","unstructured":"Johnston ME, Treharne GJ, Chapman PT, Stamp LK. Patient information about gout: an international review of existing educational resources. J Rheumatol. 2015;42(6):975\u20138.","journal-title":"J Rheumatol"},{"key":"744_CR36","unstructured":"Pharmaceutical Society of Australia. Dispensing practice guidelines. 2017. http:\/\/www.psa.org.au\/wp-content\/uploads\/Dispensing-Practice-Guidelines-2017-pdf-8.3MB.pdf . Accessed 15 Feb 2018."},{"key":"744_CR37","unstructured":"The Department of Health. Sixth Community Pharmacy Agreement. 2015. http:\/\/www.pbs.gov.au\/general\/pbs-access-sustainability\/signed-sixth-community-pharmacy-agreement-commonwealth-and-pharmacy-guild.pdf . Accessed 1 Oct 2017."},{"issue":"7","key":"744_CR38","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1532-5415.2007.01202.x","volume":"55","author":"MA Raebel","year":"2007","unstructured":"Raebel MA, Charles J, Dugan J, Carroll NM, Korner EJ, Brand DW, et al. Randomized trial to improve prescribing safety in ambulatory elderly patients. J Am Geriatr Soc. 2007;55(7):977\u201385.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"744_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/jcpt.12168","volume":"39","author":"C Curtain","year":"2014","unstructured":"Curtain C, Peterson G. Review of computerized clinical decision support in community pharmacy. J Clin Pharm Ther. 2014;39(4):343\u20138.","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"744_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2125.2007.03012.x","volume":"65","author":"JF Reeve","year":"2008","unstructured":"Reeve JF, Tenni PC, Peterson GM. An electronic prompt in dispensing software to promote clinical interventions by community pharmacists: a randomized controlled trial. Br J Clin Pharmacol. 2008;65(3):377\u201385.","journal-title":"Br J Clin Pharmacol"}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-018-0744-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12875-018-0744-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-018-0744-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:07:28Z","timestamp":1751627248000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-018-0744-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["744"],"URL":"https:\/\/doi.org\/10.1186\/s12875-018-0744-3","relation":{},"ISSN":["1471-2296"],"issn-type":[{"value":"1471-2296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"7 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for the study was obtained from The University of New South Wales Human Research Ethics Advisory Panel (reference #2014\u20137-10).Informed consent to participate in the study was obtained in writing from each participant prior to commencement of interviews.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"54"}}